Download Full Text (925 KB)
Antimicrobial therapy is essential to treat cystic fibrosis (CF) lung infections. Empiric antimicrobial selection is generally based on previous culture information and, if available, an institution-specific antibiogram (ABGM). Most institutions antibiograms exclude cultures from individuals with cystic fibrosis, imposing challenges with empiric antimicrobial selection and monitoring susceptibility patterns over time. A cystic fibrosis-specific antibiogram may help drive population-specific antimicrobial selection and improve antimicrobial stewardship.
Infectious Disease | Pathology | Pharmacy and Pharmaceutical Sciences | Pulmonology
Elson, Claire; Meier, Ellen; Swanson, Douglas; Selvarangan, Rangaraj; Gripka, Megan; and Oermann, Christopher M., "Development and Interim Analysis of a Cystic Fibrosis-Specific Antibiogram" (2020). Posters. 255.